Ligand validation:6PY9

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PY9_GOL_A_525	96%	50%	0.076	0.984	0.85	1.08	-	-	1	0	100%	0.9
6PY9_GOL_B_522	72%	54%	0.116	0.941	0.71	1.04	-	-	1	0	100%	0.85
6PY9_GOL_A_527	66%	55%	0.132	0.936	0.72	1	-	-	1	0	100%	0.83
6PY9_GOL_A_528	60%	52%	0.17	0.955	0.98	0.9	-	-	0	0	100%	0.92
6PY9_GOL_B_520	59%	53%	0.165	0.946	0.99	0.83	-	-	1	0	100%	1
6PY9_GOL_A_523	52%	50%	0.161	0.92	0.92	1	-	-	2	0	100%	0.98
6PY9_GOL_A_526	52%	52%	0.166	0.925	1.04	0.83	-	-	2	0	100%	0.74
6PY9_GOL_C_523	51%	54%	0.147	0.902	0.77	1.02	-	-	1	0	100%	1
6PY9_GOL_A_524	49%	53%	0.177	0.925	0.86	0.97	-	-	1	0	100%	1
6PY9_GOL_B_523	37%	51%	0.148	0.846	0.78	1.11	-	1	0	0	100%	0.76
6PY9_GOL_C_522	35%	48%	0.144	0.831	0.95	1.04	-	-	0	0	100%	1
6PY9_GOL_D_519	23%	51%	0.249	0.872	0.94	0.95	-	-	2	0	100%	0.87
6PY9_GOL_B_521	6%	49%	0.392	0.821	0.96	0.99	-	-	0	0	100%	0.88
4DHL_GOL_A_504	100%	90%	0.031	0.991	0.38	0.23	-	-	0	0	100%	1
4DSY_GOL_A_504	98%	86%	0.05	0.975	0.34	0.38	-	-	0	0	100%	1
8BRN_GOL_D_518	98%	51%	0.061	0.984	0.87	1.01	-	-	0	0	100%	0.95
6HWR_GOL_A_516	96%	45%	0.068	0.976	1.02	1.11	-	-	1	0	100%	1
4DT2_GOL_C_508	77%	83%	0.101	0.941	0.32	0.46	-	-	1	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.